Global Kinase Inhibitors For Cancer Treatment Market size is expected to be worth around US$ 151.7 Billion by 2034.

Global Plasma-Derived Drugs Market size is expected to be worth around US$ 35.5 Billion by 2034 from US$ 16.3 Billion in 2024.

As Breast Cancer Awareness Month approaches in October, advances in antibody–drug conjugates, endocrine therapy and molecular profiling are changing the management of metastatic breast cancer.

- 10x Genomics TXG-- stock surged 820% from $11.16 to $102.81 then fell 26% to $76, driven by Atera SORA-- product optimism ...

Metagenomic sequencing of water from the Ganga River at Haridwar has uncovered thousands of viral species dominated by tailed ...

The extraordinary lifespan variation in domestic dogs provides a natural experiment for testing how intrinsic rates of ...

The job of superintendent will change substantially in January, thanks to AB 181, which Gov. Gavin Newsom signed in July, transferring management of the California Department of Education from the ...

TXG fell 13.55% to $84.50 from $97.74 the previous trading day Weiss Ratings assigns D- (Sell) Market cap is $12.18B 10x ...

Italfarmaco S.p.A., a global pharmaceutical company with established expertise in histone deacetylase (HDAC) biology and therapeutic development, and VeriSIM Life, an AI-enabled drug discovery and ...

The 2026 Global Ranking of Academic Subjects assessed around 2,000 universities across 57 academic subjects; USP stood out in ...